Pf-07265807

Other Medications

EU Experimental ES Not available 1 Clinical Trials

Description

Pf-07265807 is an experimental drug that has been studied in clinical trials for certain types of advanced or metastatic solid tumors, including colorectal cancer. It was investigated in Phase 1 trials to determine its safety, how the body processes it (pharmacokinetics), and what dose might be appropriate for further studies. These trials involved patients with advanced cancers, including those with microsatellite stable (MSS) tumors and varying levels of PD-L1 expression. The trials have been terminated. This means that the drug is not currently being actively studied in CRC trials, and it is not approved for use in colorectal cancer or any other cancer.

Mechanism of Action

Pf-07265807 is being studied as a potential treatment for solid tumors. The specific way it works (its mechanism of action) is being investigated in clinical trials. It is being tested alone and in combination with other drugs like axitinib and sasanlimab.

Side Effects

Because Pf-07265807 is an experimental drug and the trials have been terminated Specific side effect information from completed trials is limited. As with any experimental drug Participants in the trials experienced side effects Which were monitored closely to assess safety and tolerability. Detailed information about specific side effects is typically found in the trial reports Which are not always publicly available. Since the drug is not approved and trials are terminated It is not available for patients.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT04458259 Phase 1
Terminated
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
United States, Canada, Italy, Japan, Spain

Quick Info

CategoryOther Medications
EU EMA StatusExperimental
ES Spain AccessNot available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
787 trials
Leucovorin
Other Medications
648 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.